Company Filing History:
Years Active: 2022
Title: Raju Subramanian: Innovator in Antiviral Drug Development
Introduction
Raju Subramanian is a notable inventor based in San Mateo, California. He has made significant contributions to the field of antiviral drug development, particularly in relation to HIV treatment. His innovative work has led to the creation of valuable patents that enhance the understanding and application of antiviral therapies.
Latest Patents
Raju Subramanian holds a patent for "Metabolites of bictegravir." This invention provides metabolites of the antiviral drug bictegravir, including compositions and salts thereof. These metabolites are useful in the prevention and treatment of HIV, as well as in analytical methods related to the administration of bictegravir. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Raju Subramanian is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on antiviral drugs. His role at Gilead has allowed him to work on groundbreaking research that has the potential to improve the lives of individuals affected by HIV.
Collaborations
Throughout his career, Raju has collaborated with talented professionals in the field. Some of his notable coworkers include Haolun Jin and Hyung-Jung Pyun. These collaborations have fostered an environment of innovation and have contributed to the success of their projects.
Conclusion
Raju Subramanian is a dedicated inventor whose work in antiviral drug development is making a significant impact in the fight against HIV. His innovative contributions and collaborations highlight the importance of research in advancing healthcare solutions.